Member login | Not a member? Sign up
Cyprotex is a contract research organisation that helps to identify the most prospective drug compounds. The company specialises in Absorption, Distribution, Metabolism, Excretion / Toxicity data for drug compounds. Cyprotex joined Aim on 15 February 2002. It raised £5.5m net at 29p a share, which valued the company at £26.2m.
Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds